Health · 1 views
Focal therapy use remains uncommon in nonmetastatic prostate cancer
For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use was defined as inappropriate in about half of recipients, according to a research letter published online Aug. 13 in…
Summary
Andrea Cosenza, M.D., from the University of Pittsburgh Medical Center, and colleagues conducted a retrospective study using the National Cancer Database to examine patterns and temporal trends in focal therapy use among U.S. patients ages 50 and older with nonmetastatic prostate cancer diagnosed between 2010 and 2023. Focal therapy use in low-, high- or very high-risk disease was defined as inappropriate.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- The Guardian view on extreme heat: its scale should be a wake-up call to us all | EditorialContinue reading
- My dad’s determination to choose life despite his cruel illness has taught me gratitude | Nomi KaltmannContinue reading
- Older athletes show aging need not bring major losses in fitness or independenceContinue reading
- What is postpartum psychosis?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow